Who Buys Nystatin from India — 458 Importers Behind a $52.3M Market
India's nystatin import market is served by 458 active buyers who collectively imported $52.3M across 2,442 shipments. M/S. GITTOES PHARMACEUTICALS LTD. (UGANDA) leads with a 19.9% market share, followed by EVERSANA LIFE SCIENCE SERVICES and TORRENT PHARMA INC. The top 5 buyers together control 58.0% of total import value, reflecting a moderately competitive buyer landscape.
Nystatin buyer data — 458 importers · $52.3M market · 2,442 shipmentsTransData Nexus · Indian Customs Data
Top Nystatin Importers — Ranked by Import Value
M/S. GITTOES PHARMACEUTICALS LTD. (UGANDA) is the leading nystatin importer from India, holding a 19.9% share of the $52.3M market across 2,442 shipments from 458 buyers. The top 5 buyers — M/S. GITTOES PHARMACEUTICALS LTD. (UGANDA), EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), TORRENT PHARMA INC (UNITED STATES), LEADING PHARMA LLC (UNITED STATES), GENERICS & SPECIALITIES LDA ,VALE D (MOZAMBIQUE) — collectively control 58.0% of total import value.
Top Nystatin Buyers & Importers
Ranked by import value · 458 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Nystatin Buyers & Importers — Ranked by Import Value. 458 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Nystatin — and from which countries?
Flow of Nystatin exports from India: each country's share and the named importers behind the numbers
Nystatin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 75.8% of global Nystatin imports — led by United States (40.9%) with a total trade value of $52.3M across 2,442 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $21.4M through 601 shipments. This represents a market share of 40.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• EVERSANA LIFE SCIENCE SERVICES - $6.7M (31.4% of country's total business)
• TORRENT PHARMA INC - $4.5M (21.0% of country's total business)
• LEADING PHARMA LLC - $4.5M (20.9% of country's total business)
• AVET PHARMACCEUTICALS INC - $1.4M (6.5% of country's total business)
• EVERSANA LIFE SCIENCE SERVICES.. - $1.3M (5.9% of country's total business)
• Rest of United States's importers - $3.1M (14.4% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $35.6K, indicating premium pricing strategy compared to the market average of $21.4K.
United States is a key market for Nystatin imports, representing 40.9% of total trade value.
The importation of Nystatin from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like M/S. Gittoes Pharmaceuticals Ltd. (Uganda) and Universal Co. Ltd. (Myanmar) function as intermediaries, procuring Nystatin in bulk to supply to pharmacies, hospitals, and clinics. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
Contract Manufacturers: Companies such as Eversana Life Science Services (United States) and Avet Pharmaceuticals Inc. (United States) import Nystatin as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement is driven by manufacturing schedules and market demand, leading to substantial, periodic orders.
Government Procurement Agencies: Organizations like Generics & Specialities LDA, Vale D (Mozambique) and Pharma Zee SURL (Tanzania) often engage in tender-based purchasing to supply public health facilities. Their buying behavior is influenced by government budgets, healthcare policies, and disease prevalence, resulting in large, scheduled procurements.
Import regulations for Nystatin vary across the top importing countries:
United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Requires submission of a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) for generic drugs, including comprehensive data on safety, efficacy, and manufacturing.
Estimated Timeline: Typically 10 months for standard reviews; priority reviews may be expedited to 6 months.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049029 are generally duty-free.
Uganda:
Regulatory Authority: National Drug Authority (NDA).
The demand for Nystatin in importing countries is influenced by several factors:
Disease Prevalence: Nystatin is primarily used to treat fungal infections, including candidiasis. High prevalence rates of such infections, especially in immunocompromised populations, drive demand.
Government Healthcare Programs: Many countries have initiatives to improve access to essential medicines. For instance, the inclusion of Nystatin in national essential medicines lists facilitates procurement and distribution.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage increase the availability of essential medicines, including antifungals like Nystatin, in public health facilities.
WHO Essential Medicines List Procurement: Nystatin's inclusion in the WHO Essential Medicines List encourages its procurement by international health organizations and governments, ensuring its availability in resource-limited settings.
Common Questions — Nystatin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest nystatin buyer importing from India?
Based on import volume and value, M/S. GITTOES PHARMACEUTICALS LTD. (UGANDA) leads with $10.4M in imports and a 19.9% market share — the highest of any single nystatin importer. EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) and TORRENT PHARMA INC (UNITED STATES) are the next largest buyers.
QHow many companies buy nystatin from India?
There are 458 active nystatin buyers importing from India, with a combined market of $52.3M across 2,442 shipments to 96 countries. The top 5 buyers hold 58.0% of total import value, while the remaining 453 buyers handle the other 42.0%.
QWhich countries import the most nystatin from India?
The top importing countries for nystatin from India are United States (40.9%), Uganda (20.4%), Mozambique (9.5%), Nigeria (2.6%), Dominican Republic (2.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of nystatin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for nystatin from India?
The average import transaction value for nystatin from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
The importation of Nystatin from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like M/S. Gittoes Pharmaceuticals Ltd. (Uganda) and Universal Co. Ltd. (Myanmar) function as intermediaries, procuring Nystatin in bulk to supply to pharmacies, hospitals, and clinics. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
Contract Manufacturers: Companies such as Eversana Life Science Services (United States) and Avet Pharmaceuticals Inc. (United States) import Nystatin as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement is driven by manufacturing schedules and market demand, leading to substantial, periodic orders.
Government Procurement Agencies: Organizations like Generics & Specialities LDA, Vale D (Mozambique) and Pharma Zee SURL (Tanzania) often engage in tender-based purchasing to supply public health facilities. Their buying behavior is influenced by government budgets, healthcare policies, and disease prevalence, resulting in large, scheduled procurements.
Import regulations for Nystatin vary across the top importing countries:
United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Requires submission of a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) for generic drugs, including comprehensive data on safety, efficacy, and manufacturing.
Estimated Timeline: Typically 10 months for standard reviews; priority reviews may be expedited to 6 months.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049029 are generally duty-free.
Uganda:
Regulatory Authority: National Drug Authority (NDA).
The demand for Nystatin in importing countries is influenced by several factors:
Disease Prevalence: Nystatin is primarily used to treat fungal infections, including candidiasis. High prevalence rates of such infections, especially in immunocompromised populations, drive demand.
Government Healthcare Programs: Many countries have initiatives to improve access to essential medicines. For instance, the inclusion of Nystatin in national essential medicines lists facilitates procurement and distribution.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage increase the availability of essential medicines, including antifungals like Nystatin, in public health facilities.
WHO Essential Medicines List Procurement: Nystatin's inclusion in the WHO Essential Medicines List encourages its procurement by international health organizations and governments, ensuring its availability in resource-limited settings.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
2Uganda
Uganda emerges as the second largest importing country, achieving a total trade value of $10.6M through 14 shipments. This represents a market share of 20.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Uganda has a diverse importer base, with their top importers including:
• M/S. GITTOES PHARMACEUTICALS LTD. - $10.4M (97.9% of country's total business)
Key Insight: Uganda demonstrates strong market positioning with an average shipment value of $760.4K, indicating premium pricing strategy compared to the market average of $21.4K.
Uganda is a key market for Nystatin imports, representing 20.4% of total trade value.
Primary Market
Secondary Market
3Mozambique
Mozambique emerges as the third largest importing country, achieving a total trade value of $5.0M through 6 shipments. This represents a market share of 9.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Mozambique has a diverse importer base, with their top importers including:
• GENERICS & SPECIALITIES LDA ,VALE D - $4.3M (85.7% of country's total business)
• GENERICS AND SPECIALITIES LIMITADA - $306.8K (6.2% of country's total business)
Key Insight: Mozambique demonstrates strong market positioning with an average shipment value of $827.0K, indicating premium pricing strategy compared to the market average of $21.4K.
Mozambique is a key market for Nystatin imports, representing 9.5% of total trade value.
Primary Market
Secondary Market
4Nigeria
Nigeria emerges as the fourth largest importing country, achieving a total trade value of $1.4M through 31 shipments. This represents a market share of 2.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Nigeria has a diverse importer base, with their top importers including:
• M/S,GREAT TIMEC PHARMA CO, LTD, - $337.6K (24.6% of country's total business)
• ANLEOSON PHARMACEUTICALS LIMITED - $269.3K (19.6% of country's total business)
Key Insight: Nigeria demonstrates strong market positioning with an average shipment value of $44.2K, indicating premium pricing strategy compared to the market average of $21.4K.
Nigeria is a key market for Nystatin imports, representing 2.6% of total trade value.
Primary Market
Secondary Market
5Dominican Republic
Dominican Republic emerges as the fifth largest importing country, achieving a total trade value of $1.3M through 45 shipments. This represents a market share of 2.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Dominican Republic has a diverse importer base, with their top importers including:
• BALAXI HEALTHCARE DOMINICANA SRL - $699.4K (55.0% of country's total business)
• SALDENT INTERNACIONAL S.R.L., - $312.6K (24.6% of country's total business)
Key Insight: Dominican Republic demonstrates strong market positioning with an average shipment value of $28.2K, indicating premium pricing strategy compared to the market average of $21.4K.
Dominican Republic is a key market for Nystatin imports, representing 2.4% of total trade value.
Primary Market
Secondary Market
Retail Chains and Hospital Groups: While not explicitly listed among the top buyers, these entities typically procure Nystatin to meet patient needs, with purchasing patterns reflecting patient demand and inventory management practices.
Re-exporters: Some buyers may act as re-exporters, importing Nystatin for distribution to neighboring countries, especially in regions with limited direct access to Indian pharmaceutical products.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Submission of a product dossier, including quality, safety, and efficacy data, followed by evaluation and approval.
Estimated Timeline: Approximately 12 months, subject to completeness of documentation.
Import Tariff/Duty: Pharmaceuticals are typically exempt from import duties to promote healthcare access.
Mozambique:
Regulatory Authority: Pharmacy Department of the Ministry of Health.
Import Registration Process: Requires submission of a registration dossier, including product specifications and clinical data.
Estimated Timeline: Around 12 to 18 months, depending on the product complexity.
Import Tariff/Duty: Essential medicines are often exempt from import duties; however, verification with local authorities is recommended.
Nigeria:
Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).
Import Registration Process: Involves submission of a registration dossier, facility inspection, and product testing.
Estimated Timeline: Approximately 12 months, subject to regulatory workload.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049029 are generally exempt from import duties.
Dominican Republic:
Regulatory Authority: Dirección General de Medicamentos, Alimentos y Productos Sanitarios (DIGEMAPS).
Import Registration Process: Submission of a registration application with product details, manufacturing information, and clinical data.
Estimated Timeline: Approximately 6 to 12 months, depending on the product and completeness of the application.
Import Tariff/Duty: Pharmaceutical products are typically subject to a 0% import duty, but verification with customs authorities is advisable.
It is essential for exporters to stay updated with the latest regulations and tariffs, as these can change based on policy revisions and international trade agreements.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many governments and health organizations procure medicines through competitive tendering processes, ensuring cost-effectiveness and consistent supply.
With 458 buyers across 96 countries, the market for Nystatin is substantial. Understanding these demand drivers enables suppliers to align their strategies with market needs, ensuring sustained growth and contribution to global health.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$21.4K
$26.10 per unit
Retail Chains and Hospital Groups: While not explicitly listed among the top buyers, these entities typically procure Nystatin to meet patient needs, with purchasing patterns reflecting patient demand and inventory management practices.
Re-exporters: Some buyers may act as re-exporters, importing Nystatin for distribution to neighboring countries, especially in regions with limited direct access to Indian pharmaceutical products.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Submission of a product dossier, including quality, safety, and efficacy data, followed by evaluation and approval.
Estimated Timeline: Approximately 12 months, subject to completeness of documentation.
Import Tariff/Duty: Pharmaceuticals are typically exempt from import duties to promote healthcare access.
Mozambique:
Regulatory Authority: Pharmacy Department of the Ministry of Health.
Import Registration Process: Requires submission of a registration dossier, including product specifications and clinical data.
Estimated Timeline: Around 12 to 18 months, depending on the product complexity.
Import Tariff/Duty: Essential medicines are often exempt from import duties; however, verification with local authorities is recommended.
Nigeria:
Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).
Import Registration Process: Involves submission of a registration dossier, facility inspection, and product testing.
Estimated Timeline: Approximately 12 months, subject to regulatory workload.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049029 are generally exempt from import duties.
Dominican Republic:
Regulatory Authority: Dirección General de Medicamentos, Alimentos y Productos Sanitarios (DIGEMAPS).
Import Registration Process: Submission of a registration application with product details, manufacturing information, and clinical data.
Estimated Timeline: Approximately 6 to 12 months, depending on the product and completeness of the application.
Import Tariff/Duty: Pharmaceutical products are typically subject to a 0% import duty, but verification with customs authorities is advisable.
It is essential for exporters to stay updated with the latest regulations and tariffs, as these can change based on policy revisions and international trade agreements.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many governments and health organizations procure medicines through competitive tendering processes, ensuring cost-effectiveness and consistent supply.
With 458 buyers across 96 countries, the market for Nystatin is substantial. Understanding these demand drivers enables suppliers to align their strategies with market needs, ensuring sustained growth and contribution to global health.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 458 global importers of Nystatin identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 2,442 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 96 destination countries with market share per buyer calculated from capped values.
